Our study focuses on demonstrating the underlying mechanisms of IFN-γ-stimulated melanoma progression and developing novel inhibitors targeting the IFN-γ-mediated signaling pathway for melanoma prevention and therapy. The gene discussed is IFNG; the disease is melanoma.